Literature DB >> 32628342

Factors associated with social functioning among long-term cancer survivors treated with hematopoietic stem cell transplantation as adolescents or young adults.

Casey A Walsh1,2, Jean C Yi2, Abby R Rosenberg3,4,5,6, Marie-Laure V Crouch2, Wendy M Leisenring2, Karen L Syrjala2,7.   

Abstract

OBJECTIVE: Hematopoietic stem cell transplantation (HSCT) can compromise long-term health and social functioning. We examined the impact of physical and social-emotional factors on the social functioning of long-term adolescent and young adult (AYA) HSCT survivors.
METHODS: This cross-sectional analysis included HSCT recipients from the INSPIRE trial [NCT00799461] who received their first transplant between ages 15-39. Patient-reported outcome measures included the Short Form-36v2, Fatigue Symptom Inventory, Cancer and Treatment Distress, and the ENRICHD Social Support Inventory. We used hierarchical multiple linear regression to identify physical and social-emotional factors associated with social functioning at the baseline assessment, with the first block including sociodemographic and clinical factors significant at P = <0.10 in univariate testing, the second block including fatigue and physical function, and the third block including social support and distress.
RESULTS: Participants (N = 279) were 52% male and 93.5% white, non-Hispanic, with a mean age of 30.3 (SD 6.6) at first transplant. Social Functioning mean was 48.5 (SD 10.5), below age-adjusted norms (t = -13.6, P = <0.001). In the first block, current chronic graft-vs-host disease accounted for 5.5% of the variance (P = <0.001). Adding fatigue and physical function explained an additional 46.6% of the variance (P = <0.001). Adding distress and social support explained an additional 7.7% of the variance (P = <0.001). The final model explained 59.8% of the variance; distress, fatigue, and physical function were significantly associated with social functioning.
CONCLUSIONS: Distress, fatigue, and physical function are associated with social functioning and interventions targeting these symptoms may help to improve SF among long-term cancer survivors treated with HSCT as AYAs.
© 2020 John Wiley & Sons Ltd.

Entities:  

Keywords:  AYA; adolescent and young adult; cancer; cancer survivorship; distress; fatigue; hematologic malignancy; hematopoietic stem cell transplantation; psycho-oncology; social functioning

Mesh:

Year:  2020        PMID: 32628342      PMCID: PMC7721997          DOI: 10.1002/pon.5460

Source DB:  PubMed          Journal:  Psychooncology        ISSN: 1057-9249            Impact factor:   3.894


  32 in total

1.  Physical and psychosocial aspects of adolescent and young adults after allogeneic hematopoietic stem-cell transplantation: results from a prospective multicenter trial.

Authors:  Kristin Pulewka; Daniel Wolff; Philipp Y Herzberg; Hildegard Greinix; Pia Heussner; Friederike H A Mumm; Stephanie von Harsdorf; Kathrin Rieger; Philipp Hemmati; Andreas Hochhaus; Inken Hilgendorf
Journal:  J Cancer Res Clin Oncol       Date:  2017-04-19       Impact factor: 4.553

Review 2.  Distress management.

Authors:  Jimmie C Holland; Barbara Andersen; William S Breitbart; Luke O Buchmann; Bruce Compas; Teresa L Deshields; Moreen M Dudley; Stewart Fleishman; Caryl D Fulcher; Donna B Greenberg; Carl B Greiner; George F Handzo; Laura Hoofring; Charles Hoover; Paul B Jacobsen; Elizabeth Kvale; Michael H Levy; Matthew J Loscalzo; Randi McAllister-Black; Karen Y Mechanic; Oxana Palesh; Janice P Pazar; Michelle B Riba; Kristin Roper; Alan D Valentine; Lynne I Wagner; Michael A Zevon; Nicole R McMillian; Deborah A Freedman-Cass
Journal:  J Natl Compr Canc Netw       Date:  2013-02-01       Impact factor: 11.908

3.  What do adolescents and young adults want from cancer resources? Insights from a Delphi panel of AYA patients.

Authors:  Christabel K Cheung; Brad Zebrack
Journal:  Support Care Cancer       Date:  2016-08-31       Impact factor: 3.603

4.  Cancer and treatment distress psychometric evaluation over time: A BMT CTN 0902 secondary analysis.

Authors:  Karen L Syrjala; Steven K Sutton; Heather S L Jim; Jennifer M Knight; William A Wood; Stephanie J Lee; Paul B Jacobsen; Muneer H Abidi; Jean C Yi
Journal:  Cancer       Date:  2016-11-28       Impact factor: 6.860

Review 5.  Teenage and Young Adult Cancer-Related Fatigue Is Prevalent, Distressing, and Neglected: It Is Time to Intervene. A Systematic Literature Review and Narrative Synthesis.

Authors:  Anna Spathis; Sara Booth; Sarah Grove; Helen Hatcher; Isla Kuhn; Stephen Barclay
Journal:  J Adolesc Young Adult Oncol       Date:  2015-03       Impact factor: 2.223

6.  "From Snail Mode to Rocket Ship Mode": Adolescents and Young Adults' Experiences of Returning to Work and School After Hematopoietic Cell Transplantation.

Authors:  Eden R Brauer; Huibrie C Pieters; Patricia A Ganz; Wendy Landier; Carol Pavlish; MarySue V Heilemann
Journal:  J Adolesc Young Adult Oncol       Date:  2017-06-08       Impact factor: 2.223

7.  Psychometric properties of the Cancer and Treatment Distress (CTXD) measure in hematopoietic cell transplantation patients.

Authors:  Karen L Syrjala; Jean C Yi; Shelby L Langer
Journal:  Psychooncology       Date:  2015-06-29       Impact factor: 3.894

8.  Developing a Risk Prediction Model for Long-Term Physical and Psychological Functioning after Hematopoietic Cell Transplantation.

Authors:  Annemarie M J Braamse; Jean C Yi; Otto J Visser; Martijn W Heymans; Berno van Meijel; Joost Dekker; Karen L Syrjala
Journal:  Biol Blood Marrow Transplant       Date:  2015-12-11       Impact factor: 5.742

9.  Measurement of fatigue in cancer patients: development and validation of the Fatigue Symptom Inventory.

Authors:  D M Hann; P B Jacobsen; L M Azzarello; S C Martin; S L Curran; K K Fields; H Greenberg; G Lyman
Journal:  Qual Life Res       Date:  1998-05       Impact factor: 4.147

Review 10.  Unique Challenges of Hematopoietic Cell Transplantation in Adolescent and Young Adults with Hematologic Malignancies.

Authors:  Parinda A Mehta; Seth J Rotz; Navneet S Majhail
Journal:  Biol Blood Marrow Transplant       Date:  2018-09-19       Impact factor: 5.742

View more
  6 in total

1.  Psychosocial and financial issues after hematopoietic cell transplantation.

Authors:  David Buchbinder; Nandita Khera
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2021-12-10

Review 2.  Biobehavioral Implications of Covid-19 for Transplantation and Cellular Therapy Recipients.

Authors:  Jennifer M Knight; Mallory R Taylor; Kelly E Rentscher; Elisabeth C Henley; Hannah A Uttley; Ashley M Nelson; Lucie M Turcotte; Natalie S McAndrew; Hermioni L Amonoo; Lathika Mohanraj; Debra Lynch Kelly; Erin S Costanzo
Journal:  Front Immunol       Date:  2022-07-05       Impact factor: 8.786

3.  Mediating effect of ill perception on the relationship between social constraints and fear of cancer recurrence among adolescent and young adult survivors who underwent hematopoietic stem cell transplantation.

Authors:  Zhiying Shen; Jianfei Xie; Chunhong Ruan; Chengyuan Li
Journal:  Asia Pac J Oncol Nurs       Date:  2022-04-07

Review 4.  Haematopoietic Stem Cell Transplantation in Adolescents and Young Adults With Acute Lymphoblastic Leukaemia: Special Considerations and Challenges.

Authors:  Charlotte Calvo; Leila Ronceray; Nathalie Dhédin; Jochen Buechner; Anja Troeger; Jean-Hugues Dalle
Journal:  Front Pediatr       Date:  2022-01-11       Impact factor: 3.418

5.  The mediating effect of social functioning on the relationship between social support and fatigue in middle-aged and young recipients with liver transplant in China.

Authors:  Dan Zhang; Junling Wei; Xiaofei Li
Journal:  Front Psychol       Date:  2022-08-03

6.  Systematic Review: Sleep Disorders Based on Objective Data in Children and Adolescents Treated for a Brain Tumor.

Authors:  Anne Sophie Lind Helligsoe; Kathrine Synne Weile; Line Kenborg; Louise Tram Henriksen; Yasmin Lassen-Ramshad; Ali Amidi; Lisa Maria Wu; Jeanette Falck Winther; Line Pickering; René Mathiasen
Journal:  Front Neurosci       Date:  2022-02-22       Impact factor: 4.677

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.